Arvest Trust’s AbbVie ABBV Stock Holding History

Arvest Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$16.1M	Sell	93,669 -3,748	-4%	-$621K	0.96%	33
2024 Q1	$17.7M	Sell	97,417 -3,704	-4%	-$638K	1.01%	33
2023 Q4	$15.7M	Sell	101,121 -1,738	-2%	-$253K	0.94%	37
2023 Q3	$15.3M	Sell	102,859 -824	-0.8%	-$121K	1%	33
2023 Q2	$15.5M	Sell	103,683 -3,470	-3%	-$509K	0.92%	36
2023 Q1	$17.1M	Sell	107,153 -5,821	-5%	-$890K	1.06%	28
2022 Q4	$18.3M	Sell	112,974 -1,841	-2%	-$282K	1.15%	27
2022 Q3	$15.4M	Buy	114,815 +4,663	+4%	+$669K	1.06%	31
2022 Q2	$16.9M	Sell	110,152 -1,543	-1%	-$236K	1.1%	30
2022 Q1	$18.1M	Sell	111,695 -2,768	-2%	-$402K	1.01%	34
2021 Q4	$15.5M	Buy	+114,463	New	+$13.5M	0.82%	40

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arvest Trust's ABBV Position: Q2 2024 in Review

Arvest Trust reduced its AbbVie (ABBV) stake by 3.8% in Q2 2024, selling an estimated $621K and leaving 93,669 shares worth $16.1M. The position accounts for 0.96% of the portfolio, ranked #33.

Arvest Trust first reported a position in ABBV in Q4 2021 and has held it in 11 quarters since. The position peaked at $18.3M in Q4 2022. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Arvest Trust held 93,669 shares of AbbVie worth $16.1M as of Q2 2024.
Arvest Trust sold 3,748 AbbVie shares in Q2 2024, an estimated $621K.
AbbVie made up 0.96% of Arvest Trust's portfolio in Q2 2024, its #33 holding.
Arvest Trust first reported a position in AbbVie in Q4 2021 and has held it in 11 quarters since.
Arvest Trust's AbbVie position peaked at $18.3M in Q4 2022.
3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Arvest Trust's 13F filing for Q2 2024, filed 9 Aug 2024.